N Goldaracena
Overview
Explore the profile of N Goldaracena including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
9
Citations
179
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Barbas A, Dib M, Al-Adra D, Goldaracena N, Sapisochin G, Waddell T, et al.
J Cyst Fibros
. 2017 May;
17(1):e1-e4.
PMID: 28549610
Cystic fibrosis (CF) affects multiple organs including the lung, liver, and pancreas. Lung transplant, liver transplant, and combined lung-liver transplant have become well-established therapies for CF patients with end-stage organ...
2.
Goldaracena N, Spetzler V, Echeverri J, Kaths J, Cherepanov V, Persson R, et al.
Am J Transplant
. 2016 Nov;
17(4):970-978.
PMID: 27805315
Normothermic ex vivo liver perfusion (NEVLP) offers the potential to optimize graft function prior to liver transplantation (LT). Hepatitis C virus (HCV) is dependent on the presence of miRNA(microRNA)-122. Miravirsen,...
3.
Knaak M, Goldaracena N, Doyle A, Cattral M, Greig P, Lilly L, et al.
Am J Transplant
. 2016 Aug;
17(3):754-760.
PMID: 27545327
The increased prevalence of obesity worldwide threatens the pool of living liver donors. Although the negative effects of graft steatosis on liver donation and transplantation are well known, the impact...
4.
Barbas A, Goldaracena N, Dib M, Selzner M
Transplant Rev (Orlando)
. 2016 May;
30(3):154-60.
PMID: 27158081
Liver transplantation is the optimal treatment for end-stage liver disease but is limited by the severe shortage of donor organs. This shortage has prompted increased utilization of marginal grafts from...
5.
Goldaracena N, Spetzler V, Marquez M, Selzner N, Cattral M, Greig P, et al.
Am J Transplant
. 2015 Mar;
15(6):1591-7.
PMID: 25799890
We report the outcome of live donor liver transplantation (LDLT) for patients suffering from acute liver failure (ALF). From 2006 to 2013, all patients with ALF who received a LDLT...
6.
Sapisochin G, Goldaracena N, Astete S, Laurence J, Davidson D, Rafael E, et al.
Ann Surg Oncol
. 2014 Dec;
22(7):2286-94.
PMID: 25472651
Purpose: To identify prognostic factors after hepatocellular carcinoma (HCC) recurrence after liver transplantation (LT). Methods: We retrospectively reviewed the combined experience at Toronto General Hospital and Hospital Vall d'Hebron managing...
7.
Goldaracena N, Marquez M, Selzner N, Spetzler V, Cattral M, Greig P, et al.
Am J Transplant
. 2014 Oct;
14(12):2788-95.
PMID: 25277134
Outcomes of living versus deceased donor liver transplantation in patients with chronic liver disease and hepatorenal syndrome (HRS) was compared using a matched pair study design. Thirty patients with HRS...
8.
Goldaracena N, Quinonez E, Mendez P, Anders M, Orozco Ganem F, Mastai R, et al.
Transplant Proc
. 2012 Sep;
44(7):2219-22.
PMID: 22974958
Background: Although there is a worldwide need to expand the donor pool, many cadaveric marginal livers are usually discarded for transplantation. Herein, we report the outcome of a series of...
9.
McCormack L, Quinonez E, Goldaracena N, Anders M, Rodriguez V, Orozco Ganem F, et al.
Am J Transplant
. 2012 Jul;
12(10):2832-7.
PMID: 22813351
Organ shortage is the first cause of death on liver transplant waiting lists. As a consequence, we recently decided to expand liver acceptance to those organs that could potentially transmit...